Načítá se...
The challenges of introducing routine G6PD testing into radical cure: a workshop report
The only currently available drug that effectively removes malaria hypnozoites from the human host is primaquine. The use of 8-aminoquinolines is hampered by haemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. Recently a number of qualitative and a quantitative...
Uloženo v:
| Vydáno v: | Malar J |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4587750/ https://ncbi.nlm.nih.gov/pubmed/26416229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0896-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|